Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multi-centre, Non-interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients With Classical Hodgkin Lymphoma (B-HOLISTIC)

NCT03327571 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03327571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03327571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multi-centre, Non-interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients With Classical Hodgkin Lymphoma (B-HOLISTIC)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 21, 2017
Completion date
October 31, 2019
Enrollment
1,770 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

classical hodgkin lymphoma, relapsed or refractory classical hodgkin lymphoma